Skip to Main Content
TRC_PLH
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (387)
    • Blood Glucose Meters (3)
    • Complications (134)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (70)
    • Drug-Induced Hypo/Hyperglycemia (113)
    • Monitoring (77)
    • Natural Medicines/Supplements (6)
    • Prevention (26)
    • Treatment (233)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (12)
      • Bromocriptine (7)
      • Combination Products (10)
      • Gliptins (59)
      • Glitazones (85)
      • GLP-1 (33)
      • Incretin Enhancers/Mimetics (50)
      • Insulin (123)
      • Meglitinides (32)
      • Metformin (99)
      • SGLT2 Inhibitors (75)
      • Sulfonylureas (81)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (35)
  • Hypoglycemia (20)
  • Other (16)
  • Prediabetes (1)
  • Resources (172)
  • Thyroid Disorders (24)
211 - 225 of 233 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) June 2012
PL Voices: New Once WEEKLY Exenatide (Bydureon) March 2012
Commentary: Using Exenatide (Byetta) with Insulin Glargine (Lantus) December 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Commentary: New Drug: Tradjenta (Linagliptin) June 2011
Guideline: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) June 2011
Commentary: Metformin vs Pioglitazone for Polycystic Ovary Syndrome May 2011
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
Other: See new FDA information concerning the restricted use of Avandia August 2010
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) August 2010
Commentary: Cardiovascular Safety of Rosiglitazone (Avandia) – 2010 Update August 2010
  • « Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved